Peak Asset Management, LLC Gilead Sciences, Inc. Transaction History

Peak Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $430,982 - $540,067	-7,441 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $45,317 - $49,515	-714 Reduced 8.76%	7,441 $512,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $13,500 - $15,403	-225 Reduced 2.68%	8,155 $527,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $54,327 - $61,903	-959 Reduced 10.27%	8,380 $488,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $7,234 - $8,400	-100 Reduced 1.06%	9,339 $719,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $9,081 - $11,631	145 Added 1.56%	9,439 $706,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $149,674 - $164,637	-2,429 Reduced 20.72%	9,294 $604,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $18,561 - $20,814	-300 Reduced 2.5%	11,723 $792,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $4.7 Million - $5.27 Million	-75,199 Reduced 86.22%	12,023 $782,000
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $57,331 - $74,813	947 Added 1.1%	87,222 $5.46 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $80,546 - $89,179	1,130 Added 1.33%	86,275 $6.66 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $295,009 - $344,116	4,547 Added 5.64%	85,145 $6.03 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $495,821 - $604,461	6,807 Added 9.22%	80,598 $6.08 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $108,859 - $127,785	1,530 Added 2.12%	73,791 $5.29 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $5.21 Million - $6.18 Million	72,261	72,261 $5.86 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Peak Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Peak Asset Management, LLC with notifications on news.